Pneumococcal Vaccine
Pneumococcal vaccine shortage prevention strategies are presented
Published in Immunotherapy Weekly, April 5th, 2006
According to that report, "Less than one year after recommendations for the routine vaccination of infants with the newly licensed 7-valent polysaccharide-protein conjugate pneumococcal vaccine were issued in February 2000, shortages of the 7-valent polysaccharide-protein conjugate pneumococcal vaccine supply began to occur. A national shortage developed in 2001, involving both the public and private sectors, and it resulted in temporary recommendations to conserve vaccine supply for infants and young children at the highest risk...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2006-04-05)
More Articles from Immunotherapy Weekly
- Allergy & Immunology
Modified Langerhans-type dendritic cells express full-length stimulatory antigen - Allergy & Immunology
Stem cell factor is a potential therapeutic target in asthma - Autoimmune Diseases
New study shows antibody-interleukin complexes stimulate immune responses - Influenza Vaccines
Influenza vaccine supply in U.S. needs strengthening - Acute Myeloid Leukemia
Acute myeloid leukemia risk associated with treatments for Hodgkin lymphoma estimated - Adenovirus Vaccine
Vaccines elicit CD8+T cell immunity under extreme leukopenia - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
